Viewing Study NCT06182592


Ignite Creation Date: 2025-12-24 @ 3:51 PM
Ignite Modification Date: 2026-01-06 @ 7:15 PM
Study NCT ID: NCT06182592
Status: NOT_YET_RECRUITING
Last Update Posted: 2023-12-28
First Post: 2023-12-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Bridging Study of Liposomal Cytarabine-Daunorubicin in Treating Olderly Patients With Treatment-naive High-Risk (Secondary) Acute Myeloid Leukemia
Sponsor: CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module